Univeristy of Nebraska-Lincoln (UNL) scientist Ana Maria Vélez is pioneering a genetic treatment to contain western corn rootworm. The research seeks to contain agricultural pests by targeting ...

ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase ...

When it was discovered over a decade ago, RNAi seemed poised to revolutionize medicine. By working to silence defective genes, it has the potential to treat innumerable diseases. Has it delivered? In ...

Double-stranded RNA can be introduced experimentally to silence genes of interest. In plants, silencing can be triggered, for example, by engineering RNA viruses. In worms, silencing can be triggered ...

Farmers sow. Plants grow. Insects eat. Plant pests have been a fundamental challenge to farming since the beginning. Farmers have used a variety of methods for thousands of years to control the pests.

Farmers looking to gain the upper hand over corn rootworm (CRW) pests have new tools to deploy in the field, thanks to Ribonucleic acid interference (RNAi) technology. RNAi works in CRW as it feeds on ...

Johnson & Johnson has presented clinical trial data linking short-term treatment with RNAi therapy JNJ-3989 to sustained reductions in markers of hepatitis B infection. The data drop comes as J&J runs ...

Please provide your email address to receive an email when new articles are posted on . Using a novel RNA interference therapeutic improved fibrosis and reduced toxic proteins and globular burden in ...

It's been a long road for RNA interference (RNAi): From a Nobel prize and overpriced deals more than a decade ago, to the Food and Drug Administration approval of the second RNAi drug this week. As a ...

What does Mello’s prize-winning discovery do? RNAi has garnered more than its fair share of attention lately. Being the subject of a Nobel Prize will do that. But it has also left many in the area ...